Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
ADC Therapeutics SA (ADCT) had Weighted-Average Shares Outstanding (Diluted) of 97.16M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$70.84M |
|
$-157.85M |
|
$5.95M |
|
$64.89M |
|
$201.49M |
|
$-130.65M |
|
$-25.48M |
|
$-156.14M |
|
$-156.14M |
|
$-156.30M |
|
$-157.85M |
|
$-157.85M |
|
$-156.30M |
|
$-130.65M |
|
$-127.38M |
|
97.16M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
97.16M |
$-1.62 |
|
$-1.62 |
|
| Balance Sheet Financials | |
$307.39M |
|
$5.08M |
|
$14.59M |
|
$321.98M |
|
$80.47M |
|
$113.63M |
|
$444.15M |
|
$524.62M |
|
$-202.64M |
|
$-202.64M |
|
$-202.64M |
|
98.86M |
|
| Cash Flow Statement Financials | |
$-123.83M |
|
$-0.87M |
|
$97.05M |
|
$278.60M |
|
$250.87M |
|
$-27.73M |
|
$6.57M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.82 |
|
-- |
|
-- |
|
-1.28 |
|
-0.56 |
|
91.60% |
|
-184.44% |
|
-184.44% |
|
-179.82% |
|
-220.42% |
|
-222.83% |
|
$-124.70M |
|
-- |
|
-- |
|
-- |
|
0.22 |
|
0.32 |
|
3.49 |
|
104.68 |
|
77.89% |
|
77.89% |
|
-49.02% |
|
177.34% |
|
$-2.05 |
|
$-1.28 |
|
$-1.27 |
|